Compare TTI & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TTI | PAHC |
|---|---|---|
| Founded | 1981 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 1996 | 2014 |
| Metric | TTI | PAHC |
|---|---|---|
| Price | $9.40 | $32.16 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 4 |
| Target Price | $10.40 | ★ $41.25 |
| AVG Volume (30 Days) | ★ 1.5M | 250.7K |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.91% |
| EPS Growth | N/A | ★ 1883.33 |
| EPS | 0.06 | ★ 1.90 |
| Revenue | N/A | ★ $833,350,000.00 |
| Revenue This Year | $4.70 | $17.03 |
| Revenue Next Year | $11.35 | $3.82 |
| P/E Ratio | $157.00 | ★ $17.04 |
| Revenue Growth | N/A | ★ 4.12 |
| 52 Week Low | $3.17 | $25.58 |
| 52 Week High | $12.54 | $60.08 |
| Indicator | TTI | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 41.91 | 44.94 |
| Support Level | $9.21 | $30.46 |
| Resistance Level | $10.86 | $34.49 |
| Average True Range (ATR) | 0.52 | 1.22 |
| MACD | -0.14 | 0.46 |
| Stochastic Oscillator | 19.11 | 40.30 |
Tetra Technologies Inc is a diversified oil and gas services company, focused on completion fluids and associated products and services, water management, frac flowback, production well testing, offshore rig cooling, and compression services. It has two reporting segments, namely Completion Fluids & Products and Water & Flowback Services. The Completion Fluids & Products Division manufactures and markets clear brine fluids, additives, and associated products and services. The Water & Flowback Services Segment provides onshore oil and gas operators with comprehensive water management services. The majority of revenue is from the Completion Fluids & Products segment.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.